Rac-Ivabradine D6
 
		Product Description
CAT No.
				
									ALN-I014D01								
				CAS No.
				
									NA								
				Mol. F.
				
									C27H30D6N2O5								
				Mol. Wt.
				
									474.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 3-(3-(((3,4-Bis(methoxy-d3)bicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one								
				
									Smiles : CN(CCCN(CCC1=CC(OC)=C(OC)C=C1C2)C2=O)CC3C4=CC(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])C=C4C3								
				
									Inchi : InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-/i3D3,10D2								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Forced Degradation Studies of Ivabradine and In Silico Toxicology Predictions for Its New Designated Impurities
									Piotr Pikul,1 Marzena Jamru00f3giewicz,1,* Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir CiuranFront Pharmacol. 2016; 7: 117.								
				Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode
									 Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir Ciura – Front Pharmacol. 2016; 7: 117. 								
				Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis
									ElekFerenczabBélaKovácsabFranciscBodaaMohammadhassanForoughbakhshfasaeicÉva KatalinKelemenbGerg?TóthcZoltán-IstvánSzabó – Journal of Pharmaceutical and Biomedical Analysis Volume 177, 5 January 2020, 112851 								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            